C. diff Infections Cause Patient Cost and Mortality to Double

A recent study published in the journal Infection Control & Hospital Epidemiology examined the impact that C. diff infections have on the patient population. Utilizing data from a population-based cohort study among US adults, researchers found that that each year c. diff infections nearly double the patient cost and mortality chances.

Analyzing Medicare data from 2008-2010, researchers concluded that of 1,165,165 patients examined, 6,838 experienced C. diff infections. Mortality rate among patients with C. diff vs. non-infected patients was nearly double. (42.6% vs. 23.4%) Total healthcare cost for C. diff patients vs. non-infected patients was also nearly double. ($64,807 +- $66,480 vs. #38,128 +- $46,485)

Patients diagnosed with C. diff were more likely to be older, from the northeast, and demonstrated a higher burden of comorbidities. Researchers state “among elderly patients, C. diff infections are associated with an increase in adjusted mortality and healthcare associated infection cost following a CDI episode . . . nationwide, annually this equals to 240,000 patients with CDI, 46,000 potential deaths, and more than $6 billion in cost”.

Preparing for the Unexpected - May 12, 2016

Infectious disease disasters have plagued mankind throughout the course of human history. Millions have suffered and died from pandemics such as influenza, Ebloa, rotaviruses, coronaviruses such as SARS, and many more. Yet, according to...

Pathogen Outbreaks in Communities - May 10, 2016

Each year there are numerous pathogen outbreaks in a variety of communities. The first steps in infection control strategies are reduction and elimination of the pathogen. UVC Cleaning Systems technology can be extremely effective in aiding...
Page: 1234567 - All